Head & neck cancers are among the strongest areas of Japan's advanced technologies: BNCT entered routine clinical use for this group in Japan, and photo-immunotherapy is also approved for this region.
For recurrent or inoperable cases, BNCT may be considered as a targeted, often single-session option.
Photo-immunotherapy (light-activated targeted treatment) is a licensed method in Japan for the head & neck region.
Proton and heavy ion therapies provide beam precision aimed at protecting surrounding critical organs.
Selectivity and outcomes vary by tumor location, stage and prior treatments — case-specific evaluation replaces blanket statements.